We found that OXA treatment could significantly inhibit tumor growth in mice bearing mock cells rather than mice bearing ZCCHC4 OE cells, and overexpression of ZCCHC4 could attenuate OXA-induced tumor growth in vivo (Fig. 3b). This evidence concerns the gene ZCCHC4 and neoplasm.